Crossmark

Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial

Crossref DOI link: https://doi.org/10.1186/s12885-023-10671-2

Published Online: 2023-03-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

King, Amanda L.

Acquaye-Mallory, Alvina A.

Vera, Elizabeth

Mendoza, Tito

Reyes, Jennifer

Stockdill, Macy L.

Gilbert, Mark R.

Armstrong, Terri S.
Funding

Funding for this research was provided by:

Intramural Research program of the National Cancer Institute

Intramural Continuing Umbrella of Research Experiences

National Institutes of Health
License Information

Text and Data Mining valid from 2023-03-21

Version of Record valid from 2023-03-21
More Information

Article History

Received: 27 January 2023

Accepted: 22 February 2023

First Online: 21 March 2023

Declarations

:

: The protocol for this study was reviewed and approved by the NIH Institutional Review Board and all methods will be carried out in accordance with relevant guidelines and regulations for human subjects protections. Informed consent will be obtained from study participants. Participants are informed that there is no obligation to participate in this study and there will be no negative impacts on their clinical care should they choose not to take part. If patients choose to participate, they are informed that they can discontinue participation at any time and for any reason. Traditional dissemination methods (i.e. publications in peer-reviewed journals and conference presentations) will be utilized to disseminate findings of this study.

: Not applicable.

: The authors have no commercial or financial conflicts of interest to declare related to this study.

Document is current

Any future updates will be listed below